Tag: drug pricing

ISPOR Announces New Summit on Value Assessment

Summit Scheduled for October 19, 2018 in Washington, DC, USA Lawrenceville, NJ, USA—June 26, 2018—ISPOR, the professional society for health economics and outcomes research, announced a new ISPOR Summit “New Approaches to Value Assessment: Towards More Informed Pricing in Healthcare”

Posted in Announcements, ISPOR News & Press Tagged with: , , , , , , ,

ISPOR Panel Discusses Recommendations and Rationale of “Making Medicines Affordable: A National Imperative”

Session Explores Strategies to Tackle Rising Costs of Prescription Drugs in the United States Without Discouraging Development Baltimore, MD, USA—May 22, 2018—ISPOR, the professional society for health economics and outcomes research, held a session, “‘Making Medicines Affordable: A National Imperative’—Reflections

Posted in Announcements, ISPOR News & Press Tagged with: , ,

New Drugs and Medical Technologies Often Deemed “Cost-Effective but Unaffordable”

Experts Offer Pragmatic Approaches to Managing Tension Between Affordability and Cost-Effectiveness Lawrenceville, NJ, USA—March 27, 2018—Value in Health, the official journal of ISPOR (the professional society for health economics and outcomes research), announced today the publication of a series of articles

Posted in Announcements, ISPOR Journals, ISPOR News & Press, Value in Health Tagged with: , , , , , , ,

Top 10 Trends Driving Healthcare in 2018

ISPOR Announces Influential Topics in Health Economics and Outcomes Research   Lawrenceville, NJ, USA—February 6, 2018—ISPOR, the professional society for health economics and outcomes research (HEOR), announced today the release of its “Top 10 HEOR Trends” list that identifies the

Posted in Announcements, ISPOR News & Press Tagged with: , , , , , , , , , , , , , , ,

Orphan Drugs—Exploring the Challenges of Pricing, Reimbursement, and Funding

Glasgow, Scotland, UK—6 November 2017—ISPOR, the professional society for health economics and outcomes research (HEOR), held several sessions on the topic of orphan drugs at its 20th Annual European Congress, currently being held 4-8 November 2017 in Glasgow, Scotland, UK.

Posted in Announcements, ISPOR News & Press Tagged with: , , ,

Short- and Long-Term Impact of Medicare Negotiating Drug Prices: A Critical Look at the Policy Proposals

Boston, MA—May 23, 2017—The International Society for Pharmacoeconomics and Outcomes Research (ISPOR) hosted a session that explored the economic impact of Medicare directly negotiating drug prices for enrollees. The session was held this afternoon at ISPOR’s 22nd Annual International Meeting

Posted in Announcements, ISPOR News & Press Tagged with: , ,

The Relationship Between Cost Effectiveness and Affordability in Health Care

A Look at How Innovative, High-Cost Therapies Stress Payer Budgets   Boston, MA—May 23, 2017—The International Society for Pharmacoeconomics and Outcomes Research (ISPOR) hosted a session this morning at its 22nd Annual International Meeting in Boston, MA, USA that examined

Posted in Announcements, ISPOR News & Press Tagged with: ,

ISPOR 22nd Annual International Meeting to Focus on Social and Policy Change in Health Care

Conference to Be Held May 20-24, 2017 in Boston Princeton, NJ—May 9, 2017—The International Society for Pharmacoeconomics and Outcomes Research (ISPOR), the leading educational and scientific organization for health economics and outcomes research (HEOR), announced confirmation of the scientific sessions

Posted in Announcements, ISPOR News & Press Tagged with: , , , , , , , , , , , ,

PLENARY 2 OF ISPOR 19TH ANNUAL EUROPEAN CONGRESS FOCUSES ON DIFFERENTIAL PRICING OF MEDICINES IN EUROPE

Impact on Access, Innovation, and Affordability Vienna, Austria—1 November 2016—The International Society for Pharmacoeconomics and Outcomes Research (ISPOR) held its second plenary session, Differential Pricing of Medicines in Europe: Implications for Access, Innovation, and Affordability, this morning at the Society’s

Posted in Announcements, ISPOR News & Press Tagged with: , ,

ISPOR ANNOUNCES PLENARY SESSIONS AND SPEAKERS FOR 19TH ANNUAL EUROPEAN CONGRESS

To Be Held 29 October–2 November 2016 in Vienna, Austria  Princeton, NJ—September 12, 2016—The International Society for Pharmacoeconomics and Outcomes Research (ISPOR) announced plenary sessions and speakers for its 19th Annual European Congress that will be held 29 October–2 November

Posted in Announcements, ISPOR News & Press Tagged with: , , , , , , , ,